Human Liver Cancer-Associated Endothelial Cells
Quick Actions
Product Overview
Description
Human Liver Cancer is often associated with changes in the Endothelial Cells that line the blood vessels within the tumor microenvironment.
These Cancer-Associated Endothelial Cells (CAECs) play a critical role in tumor progression by supporting angiogenesis, which is the formation of new blood vessels that supply the tumor with nutrients and oxygen.
In liver cancer, these endothelial cells often exhibit altered functions and phenotypic characteristics compared to normal endothelial cells.
Guarantee expansion for a minimum of 2-5 population
doublings.
IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features
Catalog Number: NBPCAE004
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)
Characterization Markers
Positive for endothelial cell markers such as CD31
(PECAM-1) and VE-Cadherin, as verified by immunofluorescence staining or flow cytometry (FACS).
Uptake of DiI-Ac-LDL (acetylated low-density lipoprotein) as a functional marker .
Quick Facts
Product Type
Human Cancer Associated Endothelial Cells
Viability
>95% viable (Trypan Blue exclusion)
Applications
Research & Development
Availability
In Stock • Global Shipping
Technical Specifications
Applications & Use Cases
Research Areas
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Disease Modeling
Pathophysiology research
Support & Resources
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
